Evidence map›Paper›PMID 35863500›Full record

ArticleExperimental neurology2022

Aging astrocytes metabolically support aging axon function by proficiently regulating astrocyte-neuron lactate shuttle.

Chinthasagar Bastian, Sarah Zerimech, Hung Nguyen, Christine Doherty, Caroline Franke, Anna Faris, John Quinn, Selva Baltan

Open access · greenAbstract read
In one paragraph

Article in Experimental neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. White matter hyperintensities are associated with locus coeruleus atrophy and astrocytic βAlzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Lactate promotes longevity through redox-driven lipid remodeling inbioRxiv : the preprint server for biology · 2025
    Article
  9. Article
  10. Review
  11. Neurological glycogen storage diseases and emerging therapeutics.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
    Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Chinthasagar BastianDepartment of Neurosciences, Cleveland Clinic Foundation, Cleveland, OH 441952, United States of America.
Sarah ZerimechAnesthesia and Perioperative Medicine, Oregon Health and Science University, Portland, OR 97239, United States of America.
Hung NguyenAnesthesia and Perioperative Medicine, Oregon Health and Science University, Portland, OR 97239, United States of America.
Christine DohertyDepartment of Neurosciences, Cleveland Clinic Foundation, Cleveland, OH 441952, United States of America.
Caroline FrankeDepartment of Neurosciences, Cleveland Clinic Foundation, Cleveland, OH 441952, United States of America.
Anna FarisDepartment of Neurosciences, Cleveland Clinic Foundation, Cleveland, OH 441952, United States of America.
John QuinnDepartment of Neurosciences, Cleveland Clinic Foundation, Cleveland, OH 441952, United States of America.
Selva BaltanAnesthesia and Perioperative Medicine, Oregon Health and Science University, Portland, OR 97239, United States of America; Department of Neurosciences, Cleveland Clinic Foundation, Cleveland, OH 441952, United States of America. Electronic address: baltan@ohsu.edu.
Cleveland Clinic · USOregon Health & Science University · US

Funding

Vulnerability of Aging White Matter to IschemiaR01AG033720 · NIA · UNIVERSITY OF WASHINGTON · PI BALTAN, SELVA · 2010 to 2021
$2.7M
Casein kinase 2 signaling in axonal injuryR21NS094881 · NINDS · CLEVELAND CLINIC LERNER COM-CWRU · PI BALTAN, SELVA · 2016 to 2017
$436k
Vulnerability of Aging White Matter to IschemiaR56AG033720 · NIA · CLEVELAND CLINIC LERNER COM-CWRU · PI BALTAN, SELVA · 2016 to 2016
$396k
NIA NIH HHS R01 AG033720NIA NIH HHS R56 AG033720NINDS NIH HHS R21 NS094881
6 · The paper itself

Abstract

The astrocyte-neuron lactate shuttle (ANLS) is an essential metabolic support system that uptakes glucose, stores it as glycogen in astrocytes, and provides glycogen-derived lactate for axonal function. Aging intrinsically increases the vulnerability of white matter (WM) to injury. Therefore, we investigated the regulation of this shuttle to understand vascular-glial metabolic coupling to support axonal function during aging in two different WM tracts. Aging astrocytes displayed larger cell bodies and thicker horizontal processes in contrast to thinner vertically oriented processes of young astrocytes. Aging axons recovered less following aglycemia in mouse optic nerves (MONs) compared to young axons, although providing lactate during aglycemia equally supported young and aging axonal function. Incubating MONs in high glucose to upregulate glycogen stores in astrocytes delayed loss of function during aglycemia and improved recovery in both young and aging axons. Providing lactate during recovery from aglycemia unmasked a metabolic switch from glucose to lactate in aging axons. Young and aging corpus callosum consisting of a mixture of myelinated and unmyelinated axons sustained their function fully when lactate was available during aglycemia and surprisingly showed a greater resilience to aglycemia compared to fully myelinated axons of optic nerve. We conclude that lactate is a universal substrate for axons independent of their myelination content and age.

Indexed as

AstrocytesLactic AcidAgingAnimalsAxonsGlucoseGlycogenMiceNeuronsGlucoseGlycogenLactic AcidAgingAglycemiaAstrocyteLactateWhite matter

Identifiers

PMID35863500
PMCPMC11218845
OpenAlexW4285806557

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.